The interFACE Lab The Interactive and Functional Assessment of Communication and Emotion (InterFACE) Center is a natural observation laboratory designed to research emotional and behavioral deficits in people with neurological,… Read More
TrackTBI Investigator: Richard Rodgers, MD TRACK-TBI: The multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study aims to improve success of clinical trial design through the collection and analysis of… Read More
Training to Reconnect with emotional awareness therapy (TREAT) Investigators: Dawn Neumann, Flora Hammond The purpose of this study is to teach participants with traumatic brain injury to develop better emotional… Read More
Avanir Study Sheryl Katta-Charles MD, Principal Investigator A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability or AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for… Read More
Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients with Spinal Cord Injuries and Their Trained Companions Recently Initiated with the ReWalk™ Personal Device. Flora Hammond, MD (PI), funded… Read More
FOR IMMEDIATE RELEASE
Wednesday, May 13, 2015
Stephanie S. Hale, BAA, Marketing
Public Relations and Marketing
Robotic Exoskeleton that Allows Wheelchair Users to Stand and Walk is now available
for home and community use
INDIANAPOLIS, IN ? Today, Rehabilitation Hospital of Indiana announces training for the new ReWalk Robotics exoskeleton system which allows patients with spinal cord injuries to stand up and walk.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with SCI to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs. It is the first device of its kind now FDA-approved for use in the home and community.
Rehabilitation Hospital of Indiana is dedicated to providing innovative care that integrates technology with clinical expertise to optimize our patient?s outcomes. RHI?s collaboration with the ReWalk team will improve access to cutting edge technology that will help those affected by spinal cord injury and impairments. ?We are excited to be able to provide this service to our patients and their families as they progress through their journey of recovery,? said Larissa Swan, Executive Director of Therapies RHI.
Dr. Katherine Stenson, SCI Medical Director, RHI stated ?I think there is a powerful psychological benefit as well as a potential clinical benefit to the device. In our clinic it will be used as a means of exercise and therapy as well as a potential outlet for obtaining a personal device.?
ReWalk Robotics, a global leader in exoskeleton technology, offers the only FDA cleared exoskeleton systems in the United States. ReWalk manufactures two systems, the Rehabilitation model which will be utilized by RHI, as well as a Personal system which can be purchased for home use and throughout the community. Clinical studies of the ReWalk system have shown potential health benefits for the user in addition to the ability to stand and walk again including: reduction of needed medication, increase in lean muscle mass and decreased muscle spasticity, decreased body fat, decreased pain and improved pain management, and improved bowel and bladder function.
For more information contact Stephanie Hale, Rehabilitation Hospital of Indiana at email@example.com or 317-626-2910.
About Rehabilitation Hospital of Indiana
Rehabilitation Hospital of Indiana (RHI) is community collaboration between Indiana University Health and St. Vincent Health. RHI offers a full range of inpatient acute services and outpatient and vocational rehabilitation services for adults with life-changing illness and injuries in brain injury, spinal cord, stroke, amputation, orthopedic conditions, neuromuscular disease, burns and related disabilities. For more information, visit www.rhin.com
About ReWalk Robotics Ltd.
ReWalk Robotics (formerly Argo Medical Technologies) develops, manufactures and markets wearable robotic exoskeletons for people with lower limb disabilities, such as paraplegia. ReWalk?s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. ReWalk is proud to offer the only FDA cleared exoskeleton systems in the United States, for rehab and personal use respectively. Founded in 2001, ReWalk Robotics is a global company with headquarters in the US, Germany, and Israel. For more information on ReWalk Robotics and the ReWalk Systems, please visit http://www.rewalk.com.